Surgically resected human tumors reveal the biological significance of the gastric cancer stem cell markers CD44 and CD26

被引:28
作者
Nishikawa, Shimpei [1 ,2 ]
Konno, Masamitsu [1 ]
Hamabe, Atsushi [1 ,2 ]
Hasegawa, Shinichiro [1 ,2 ]
Kano, Yoshihiro [1 ,2 ]
Fukusumi, Takahito [3 ]
Satoh, Taroh [1 ]
Takiguchi, Shuji [2 ]
Mori, Masaki [2 ]
Doki, Yuichiro [2 ]
Ishii, Hideshi [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka 5650871, Japan
关键词
gastric cancer; cancer stem cell; tumor-initiating cell; chemotherapy; CD44; CD26; ACUTE MYELOID-LEUKEMIA; INITIATING CELLS; IDENTIFICATION; CHEMOTHERAPY;
D O I
10.3892/ol.2015.3063
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer tissue is maintained by relatively small populations of cancer stem cells (CSCs), which are involved in chemotherapy resistance, recurrence and metastasis. As tumor tissues are comprised of various cells, studies of human clinical samples are important for the characterization of CSCs. In the present study, an expression profiling study was performed in which an anti-cell surface marker antibody-based array platform, a flow cytometry-based cell separation technique and a tumorigenicity analysis in immunodeficient animals were utilized. These approaches revealed that the markers cluster of differentiation (CD)44 and CD26 facilitated the fractionation of surgically resected human gastric cancer (GC) cells into the following subset populations with distinct tumorigenic potentials: Highly tumorigenic CD26(+)CD44(+) cells (6/6 mice formed tumors), moderately tumorigenic CD26(+)CD44(-) cells (5/6 mice formed tumors), and weakly or non-tumorigenic CD26(-)CD44(-) cells (2/6 mice formed tumors). Furthermore, exposure to 5-fluorouracil significantly increased the proportion of CD26(+) cells in vitro. The present study demonstrated that the combined expression of CD26 and CD44 presents a potential marker of human GC stem cells.
引用
收藏
页码:2361 / 2367
页数:7
相关论文
共 50 条
[21]   Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 [J].
Takaishi, Shigeo ;
Okumura, Tomoyuki ;
Tu, Shuiping ;
Wang, Sophie S. W. ;
Shibata, Wataru ;
Vigneshwaran, Ramanathan ;
Gordon, Shanisha A. K. ;
Shimada, Yutaka ;
Wang, Timothy C. .
STEM CELLS, 2009, 27 (05) :1006-1020
[22]   CD44 AND CD24 CANNOT ACT AS CANCER STEM CELL MARKERS IN HUMAN LUNG ADENOCARCINOMA CELL LINE A549 [J].
Roudi, Raheleh ;
Madjd, Zahra ;
Ebrahimi, Marzieh ;
Samani, Fazel Sahraneshin ;
Samadikuchaksaraei, Ali .
CELLULAR & MOLECULAR BIOLOGY LETTERS, 2014, 19 (01) :23-36
[23]   Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis [J].
Wang, Wei ;
Dong, Li-Ping ;
Zhang, Ning ;
Zhao, Cheng-Hai .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (12) :5059-5066
[24]   Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man? [J].
Christine Fillmore ;
Charlotte Kuperwasser .
Breast Cancer Research, 9
[25]   Expression of CD44 and CD133 stem cell markers in squamous cell carcinoma of esophagus [J].
Gupta, Parul ;
Rizvi, Sania Z. ;
Lal, Nirupma ;
Gupta, Vishal ;
Srivastav, Anand N. ;
Musa, Osman .
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2021, 64 (03) :472-478
[26]   Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses [J].
Xia, Pu ;
Xu, Xiao-Yan .
ONCOTARGET, 2016, 7 (29) :45538-45546
[27]   Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy [J].
Hofner, Thomas ;
Macher-Goeppinger, Stephan ;
Klein, Corinna ;
Schillert, Anja ;
Eisen, Christian ;
Wagner, Steve ;
Rigo-Watermeier, Teresa ;
Baccelli, Irene ;
Vogel, Vanessa ;
Trumpp, Andreas ;
Sprick, Martin R. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (05) :678-686
[28]   Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma [J].
Kokko, Linda-Lotta ;
Hurme, Saija ;
Maula, Sanna-Mari ;
Alanen, Kalle ;
Grenman, Reidar ;
Kinnunen, Ilpo ;
Ventela, Sami .
ORAL ONCOLOGY, 2011, 47 (06) :510-516
[29]   Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer [J].
Watanabe, Toru ;
Okumura, Tomoyuki ;
Hirano, Katsuhisa ;
Yamaguchi, Tetsuji ;
Sekine, Shinichi ;
Nagata, Takuya ;
Tsukada, Kazuhiro .
ONCOLOGY LETTERS, 2017, 13 (01) :281-288
[30]   Direct reprogramming of stem cell properties in colon cancer cells by CD44 [J].
Su, Ying-Jhen ;
Lai, Hsin-Mei ;
Chang, Yi-Wen ;
Chen, Guan-Ying ;
Lee, Jia-Lin .
EMBO JOURNAL, 2011, 30 (15) :3186-3199